Southern Element Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$1.39M
- Investors
-
3
Southern Element General Information
Description
Provider of functional hemostatic polysaccharides and medical aesthetic polysaccharides, intended to provide quality products and services to various industries. The company focuses on hemostatic material and new dermal fillers applications, enabling patients with new treatment of first aid for bleeding and dermal fillers.
Contact Information
Website
www.nfybio.comCorporate Office
- 10th Floor, Block A, Zhongdanyuan
- Number 3-1, Xinjinhu Road, Jiangbei New District
- Nanjing, Jiangsu
- China
Corporate Office
- 10th Floor, Block A, Zhongdanyuan
- Number 3-1, Xinjinhu Road, Jiangbei New District
- Nanjing, Jiangsu
- China
Southern Element Timeline
Southern Element Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 11-Jul-2025 | $1.39M | Completed | Generating Revenue | ||
| 2. Early Stage VC | 16-Nov-2022 | Completed | Startup | |||
| 1. Seed Round | 01-Jan-2022 | $1.57M | $1.57M | Completed | Startup |
Southern Element Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Southern Element Patents
Southern Element Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4775664-A1 | Strain of duganella sp., exopolysaccharide produced thereby, and use | Pending | 14-Jan-2025 | ||
| US-20260199389-A1 | Strain of duganella sp., exopolysaccharide produced thereby, and use | Pending | 14-Jan-2025 | ||
| EP-4574847-A1 | Glucogalactan-based injectable subcutaneous filling hydrogel, and preparation method and use thereof | Active | 22-Dec-2023 | ||
| EP-4574847-B1 | Glucogalactan-based injectable subcutaneous filling hydrogel, and preparation method and use thereof | Active | 22-Dec-2023 | ||
| EP-4574847-C0 | Glucogalactan-based injectable subcutaneous filling hydrogel, and preparation method and use thereof | Active | 22-Dec-2023 | A61L27/20 |
Southern Element Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fosun Health Capital | Corporate Venture Capital | Minority | ||
| Lotus Lake Ventures | Venture Capital | Minority | ||
| Xiangtang Ventures | Corporate Venture Capital | Minority |
Southern Element FAQs
-
When was Southern Element founded?
Southern Element was founded in 2021.
-
Where is Southern Element headquartered?
Southern Element is headquartered in Nanjing, China.
-
What industry is Southern Element in?
Southern Element’s primary industry is Pharmaceuticals.
-
Is Southern Element a private or public company?
Southern Element is a Private company.
-
What is Southern Element’s current revenue?
The current revenue for Southern Element is .
-
How much funding has Southern Element raised over time?
Southern Element has raised $2.96M.
-
Who are Southern Element’s investors?
Fosun Health Capital, Lotus Lake Ventures, and Xiangtang Ventures have invested in Southern Element.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
